[{"AccountsPayableCurrent_0_Q3_USD":12130000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":0.0,"OtherAssetsNoncurrent_0_Q3_USD":18181000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":5259000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":1250000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":8405000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":7618000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2052000.0,"OperatingIncomeLoss_3_Q3_USD":-135408000.0,"OperatingIncomeLoss_1_Q3_USD":-59740000.0,"NumberOfReportableSegments_3_Q3_segment":1.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"NetIncomeLoss_3_Q3_USD":-146696000.0,"NetIncomeLoss_1_Q3_USD":-63445000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-168472000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-60308000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":19142000.0,"MarketableSecuritiesCurrent_0_Q3_USD":70020000.0,"LiabilitiesCurrent_0_Q3_USD":269037000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":604292000.0,"Liabilities_0_Q3_USD":1036575000.0,"InvestmentIncomeInterest_3_Q3_USD":248000.0,"InvestmentIncomeInterest_1_Q3_USD":70000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":371000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-9000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":118837000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":723000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":92514657.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":93474985.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":2565000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":1579493.0,"StockholdersEquity_0_Q3_USD":-432283000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":7512729.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":7512729.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1178625.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":379734.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":4828377.0,"ShareBasedCompensation_3_Q3_USD":30324000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":192118000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":1405000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":72125000.0,"Revenues_1_Q3_USD":54440000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_3_Q3_USD":79853000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q3_USD":25172000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1192844000.0,"RestrictedCash_0_Q3_USD":10100000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":82886000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":25726000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2952000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":17862000.0,"ProceedsFromRelatedPartyDebt_3_Q3_USD":0.0,"ProceedsFromCollaborators_3_Q3_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":20795000.0,"Revenues_3_Q3_USD":173405000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":823000.0,"InventoryNet_0_Q3_USD":6737000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":4509000.0,"Depreciation_3_Q3_USD":1062000.0,"DeferredRevenueNoncurrent_0_Q3_USD":400849000.0,"DeferredRevenueCurrent_0_Q3_USD":100564000.0,"DeferredCompensationShareBasedArrangementsLiabilityCurrent_0_Q3_USD":2724000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-146696000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-63445000.0,"CommonStockValue_0_Q3_USD":2000.0,"CommonStockSharesOutstanding_0_Q3_shares":93658206.0,"CommonStockSharesIssued_0_Q3_shares":93658206.0,"CommonStockSharesAuthorized_0_Q3_shares":564111242.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0,"CommitmentsAndContingencies_0_Q3_USD":null,"DueFromRelatedPartiesCurrent_0_Q3_USD":550000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-209638000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":527800000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":457742000.0,"AssetsCurrent_0_Q3_USD":574754000.0,"Assets_0_Q3_USD":604292000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":12130368.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":30324000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":7199000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":7199000.0,"AdditionalPaidInCapital_0_Q3_USD":777844000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q3_USD":-17285000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":642000.0,"AccountsReceivableNetCurrent_0_Q3_USD":18910000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":467842000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":93474985.0,"DueToRelatedPartiesCurrent_0_Q3_USD":391000.0,"EarningsPerShareBasic_1_Q3_USD":-0.68,"InterestExpense_3_Q3_USD":10478000.0,"InterestExpense_1_Q3_USD":3479000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":7259000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-2576000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":3641000.0,"IncreaseDecreaseInOperatingLeaseLiability_3_Q3_USD":-1326000.0,"IncreaseDecreaseInInventories_3_Q3_USD":4126000.0,"IncreaseDecreaseInDueToRelatedPartiesCurrent_3_Q3_USD":-152000.0,"IncreaseDecreaseInDueFromRelatedPartiesCurrent_3_Q3_USD":550000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":3480000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":13811000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":15340000.0,"DueToRelatedPartiesNoncurrent_0_Q3_USD":358700000.0,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":-5679000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":296000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-145638000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-63149000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":0.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":0.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":88800000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":22201000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":-0.0073,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":-0.0047,"EarningsPerShareDiluted_3_Q3_USD":-1.59,"EarningsPerShareDiluted_1_Q3_USD":-0.68,"EarningsPerShareBasic_3_Q3_USD":-1.59,"IncomeTaxExpenseBenefit_3_Q3_USD":1058000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":92514657.0,"Ticker":"MYOV","CIK":"1679082","name":"MYOVANT SCIENCES LTD.","OfficialName":"Myovant Sciences Ltd. Common Shares","form":"10-Q","period":"20211231","fy":"2022.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1001965304.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20220126"}]